Breast Cancer Trial, Recruiting NCT06100263 Sponsor: University of Michigan Rogel Cancer Center Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Recruiting

NCT06100263
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who self-identify as Black, African American, or Afro-Latina/e
  • People who are 18 years of age or older
  • People who have a confirmed breast cancer diagnosis at Stage I through Stage IIIA
  • People who have finished their main cancer treatments (such as surgery, chemotherapy, and/or radiation) within the last 5 years, noting that ongoing hormonal therapy alongside these treatments is acceptable
  • People who are not currently doing resistance exercise (such as strength training) at least 2 times per week, as recommended for cancer survivors
  • People who are able to speak and understand English

Who may not be able to join:

  • People whose breast cancer has spread to other parts of the body (metastatic disease)
  • People who have a medical reason that prevents them from doing more exercise than they currently do
  • People who have planned elective (non-emergency) surgery scheduled during the study period
  • People who are pregnant or plan to become pregnant during the study period
  • People who plan to move outside of the United States during the study period, as in-person assessments would not be possible
  • People who are currently enrolled in another exercise-based clinical trial
  • People who do not pass the exercise pre-screening process, or whose doctor does not give approval for them to increase their physical activity levels

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Angela Fong, PhD, University of Michigan Rogel Cancer Center

Phone: 1-800-865-1125

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Michigan Rogel Cancer Center
Registry
ClinicalTrials.gov
Start date
28 May 2024
Est. completion
1 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Feasibility of the exercise program (Retention); Feasibility of the exercise program (Adherence); Feasibility of the exercise program (fidelity); Satisfaction of program; Affective attitude; Perceived burden; Outcome expectation

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov